Medication adherence represents a major barrier to optimal therapeutic outcomes for a number of chronic conditions, and diabetes is no different. Often times, diabetes patients with poor glycemic control and multiple comorbidities have complex medication regimens, which often times complicate and exacerbate this problem.
Medication adherence represents a major barrier to optimal therapeutic outcomes for a number of chronic conditions, and diabetes is no different. Often times, diabetes patients with poor glycemic control and multiple comorbidities have complex medication regimens, which often times complicate and exacerbate this problem. For this reason, medication adherence was a major topic at the ADA 72nd Scientific Sessions. Here are some study highlights from the conference around this topic thus far.
Medication Adherence of Patients Attending a Pharmacist-CDE Led Diabetes Intense Medical Management and Education Clinic - Cadiz et al.
For this study, a collaborative pharmacist-endocrinologist clinic was in practice for one half day per week to help patients from a veteran population address barriers to adherence and achieve metabolic goals. The model, which was called the Diabetes Intense Medical Management (DIMM) Clinic, combined “clinical care with patient-specific diabetes education emphasizing medication and lifestyle modifications and patient empowerment,” with the objective of the clinic being to evaluate medication adherence levels between initial, 3-month, and 6-month clinic visits. Results of the study demonstrated that, “despite intense medication management that often involved additional oral agents or starting insulin therapy, patients were able to improve their medication adherence” while attending the clinic.
Hey Mikey, He Likes It: Patient Experience With Skype-Based Intervention for Teens With Poorly Controlled Diabetes - Freeman et al.
Use of videoconferencing is nothing new in the medical world. Many clinics and practices have shown positive results from telemedicine evaluations for a number of medical conditions. With that in mind, the authors of this study aimed to utilize videoconferencing as a medium to help improve medication adherence in youths with poorly controlled diabetes. The study involved 65 youths with a mean age of 15.14 years who were living in a one-parent home. The authors examined working alliance and patient satisfaction of the youths who were receiving family-based intervention to improve adherence, both via Skype (a videoconferencing, Web-based platform) versus in clinic. The researchers found that, although “parents were more satisfied with being randomized for treatment via Skype,” participants reported feeling “equally aligned with the therapist regardless of the treatment condition." Finally, Freeman et al assert that “the positive association between satisfaction with condition randomization and satisfaction with treatment via Skype highlights the importance of considering preferences when selecting treatment delivery options.”
To read more about this study, please visit the American Diabetes Association’s website.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More